CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Piramal Enterprises Limited Company Snapshot
Piramal Enterprises Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Piramal Enterprises Limited with three other companies in this sector in India: Glenmark Pharmaceuticals Ltd (2018 sales of 91.03 billion Indian Rupees [US$1.25 billion] of which 100% was Pharmaceuticals), Cadila Healthcare Ltd (119.05 billion Indian Rupees [US$1.64 billion] of which 100% was Pharmaceutical Products), and Jubilant Life Sciences Limited (75.18 billion Indian Rupees [US$1.03 billion] ).

Sales Analysis. Piramal Enterprises Limited reported sales of 106.31 billion Indian Rupees (US$1.46 billion) for the fiscal year ending March of 2018. This represents an increase of 25.0% versus 2017, when the company's sales were 85.04 billion Indian Rupees. Sales at Piramal Enterprises Limited have increased during each of the previous five years (and since 2013, sales have increased a total of 204%). Sales of Financial Services saw an increase of 48.6% in 2018, from 33.52 billion Indian Rupees to 49.82 billion Indian Rupees. Not all segments of Piramal Enterprises Limited experienced an increase in sales in 2018: sales of Healthcare Insights and Analytics fell 1.1% to 12.09 billion Indian Rupees.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Piramal Enterprises Limited
  Stock Performance Chart for Piramal Enterprises Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (9/14/2018): 3,048.65
(Figures in Indian Rupees)
1 Week 0.1%   13 Weeks 12.8%  
4 Weeks 21.9%   52 Weeks 6.4%  
 
Piramal Enterprises Limited Key Data:
  Ticker: PEL Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 106,310,300,000
(Year Ending Jan 2019).
Employees: 6,843
  Currency: Indian Rupees Market Cap: 550,563,367,806
  Fiscal Yr Ends: March Shares Outstanding: 180,592,514
  Share Type: Ordinary Closely Held Shares: 99,485,602
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.